Avextra Pharma

Avextra Pharma GmbH is a biopharmaceutical company based in Bensheim, Hesse. It develops, manufactures and markets cannabis-based prescription medicines (Rezepturarzneimittel), including a cannabis granulate, cannabis extracts and dronabinol, and offers a THC/CBD rapid test for pharmacists. The website states that the company controls the value chain from cannabis cultivation in Portugal to GMP-certified manufacturing in Germany.

The company's customers are physicians, pharmacists and patients. Its website has a healthcare-professional section with product information, batch-based certificate of analysis search, clinical study information and medical literature. The input does not describe the revenue model beyond the sale of its products.

The EU-GMP-certified production site in Bensheim is stated to be 10,000 m². The company says it invests a third of its total budget in research and development and runs clinical studies (CORAL, OCEAN-R, IMPACT). A Portuguese subsidiary, Avextra Portugal, runs a breeding program for THC and CBD cultivars. The founding year is not stated. Two job listings in Bensheim are for Quality Assurance Manager roles (clinical/GCP and GMP/GDP), although the careers page says no positions are currently open.

Product: Cannabis-based prescription galenic medicines, including cannabis granulate, extracts, dronabinol and a THC/CBD rapid test for pharmacists.